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Anticoagulant and antiplatelet medications are commonly used for the treatment and prevention of
cardiovascular diseases. We studied 84 patients who received heparin as a bridging anticoagulant and
antiplatelet therapy during the perioperative period. Hospitalization was extended for adjusting
anticoagulant and antiplatelet drugs and also bleeding complications in the perioperative period. There
were 25 instances of bleeding complications (29.7%) in this study. These complications mainly occurred
when anticoagulant and antiplatelet medications were restarted in the postoperative period. In
transurethral surgery, patients taking warfarin and antiplatelet drugs (aspirin or ticlopidine) had a statistically
signiﬁcant increase in bleeding complications compared to patients taking warfarin alone. We compared 51
cases of transurethral resection of bladder tumor, transurethral resection of the prostate holium laser
enucleation of the prostate, nephroureterectomy and percutaneous nephrolithotomy with heparinization
were compared to 692 cases with no heparinization. The heparinization group had a statistically signiﬁcant
longer hospitalization period and an increase in bleeding complications. There was one instance of
thromboembolism (1.2%) in our series. This involved stent thrombosis of a patient who had drug-eluting
stent in the left anterior descending coronary artery. She died three days postoperatively. The number of
patients taking anticoagulant and/or antiplatelet drugs is predicted to increase in the future due to aging of
the population. Guidelines for the management of anticoagulant and antiplatelet therapy in the urological
period are considered necessary.
(Hinyokika Kiyo 58 : 223-226, 2012)























HoLEP 6例，TUL 6例，前立腺全摘除術 5例，骨盤
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体的には術前 5∼ 7日に入院の上，ワーファリン，ア
スピリン，チクロピジンなど抗血栓薬を中止し，活性

































例（術中 5例，術後 4例，重複 1例），後出血 7例，
術後血尿遷延 6例，皮下血腫 3例，消化管出血 1例で
あった．術式別では出血合併症は TUR-BT，TUR-P
Table 1. Hospitalization period and timing of
restarting heparin
中央値（日) 範囲
入院日 − 7 −10-− 2
ヘパリン開始日 ＋ 1 0-＋ 5
退院日 ＋10 ＋ 2-＋73
総入院期間 18 9- 80
* 手術日を±0とする．参考 : 当科のクリティカルパス
の総入院日数 TUR-BT : 3日，TUL : 3日，RRP : 10
日，腎尿管悪性腫瘍手術 : 10日．
Table 2. Comparison between heparinization and
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Table 3. Comparison between heparinization and
no heparinization in hospitalization pe-
riod
TUR-BT 総入院期間中央値 範囲
ヘパリン置換あり (n＝25) 17 10-32
ヘパリン置換なし (n=328) 3 3-17
HoLEP および TUR-P 総入院期間中央値 範囲
ヘパリン置換あり (n＝7) 18 15-31
ヘパリン置換なし (n＝206) 4 2-14
腎尿管悪性腫瘍手術 総入院期間中央値 範囲
ヘパリン置換あり (n＝19) 20 9-80
ヘパリン置換なし (n＝140) 9 5-61
PNL 総入院期間中央値 範囲
ヘパリン置換あり (n＝2) 検討できず 16-58














































































493例に542回行われ， 5例に 5回（約 1％）の頻度で
血栓塞栓症が発症，全例重篤で 4例は死亡したと報告
している6)．
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